GE HealthCare Technologies (GEHC) Surpasses Q3 Earnings and Revenue Estimates

Core Insights - GE HealthCare Technologies (GEHC) reported quarterly earnings of $1.07 per share, exceeding the Zacks Consensus Estimate of $1.05 per share, but down from $1.14 per share a year ago, indicating an earnings surprise of +1.90% [1] - The company achieved revenues of $5.14 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 1.48% and up from $4.86 billion year-over-year [2] - GE HealthCare has consistently surpassed consensus EPS estimates over the last four quarters, achieving this four times [2] Financial Performance - The earnings surprise of +16.48% was noted in the previous quarter, where actual earnings were $1.06 compared to an expected $0.91 [1] - The current consensus EPS estimate for the upcoming quarter is $1.41, with projected revenues of $5.6 billion, while the estimate for the current fiscal year is $4.53 on revenues of $20.45 billion [7] Market Position - GE HealthCare shares have increased by approximately 1.6% since the beginning of the year, contrasting with the S&P 500's gain of 17.2% [3] - The Zacks Rank for GE HealthCare is currently 3 (Hold), indicating expected performance in line with the market in the near future [6] Industry Context - The Medical - Products industry, to which GE HealthCare belongs, is currently ranked in the bottom 42% of over 250 Zacks industries, suggesting potential challenges ahead [8] - The performance of GE HealthCare's stock may be influenced by the overall outlook for the industry [8]